JUAN
SANCHIS FORES
CATEDRÁTICO/A DE UNIVERSIDAD
![Foto de JUAN](/img/nophoto.png)
![Foto de Instituto de Salud Carlos III](/img/noimage_org.png)
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (32)
2024
-
Analysis of myocardial infarction incidence and case-fatality in the last three decades in the province of Girona
Revista Espanola de Cardiologia, Vol. 77, Núm. 6, pp. 450-458
-
Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction: The modifying role of obesity
Obesity Research and Clinical Practice
-
Carbohydrate antigen 125-guided pre-TAVI medical optimization: impact on quality of life and clinical outcomes
Revista Espanola de Cardiologia
-
Catheter-directed therapy for acute pulmonary embolism: results of a multicenter national registry
Revista Espanola de Cardiologia, Vol. 77, Núm. 2, pp. 138-147
-
ChatGPT-4 versus human assessment in cardiology peer review
Revista Espanola de Cardiologia
-
Effect of paced heart rate on quality of life and natriuretic peptides for stage B or C heart failure with preserved ejection fraction: A secondary analysis of the myPACE trial
European Journal of Heart Failure, Vol. 26, Núm. 1, pp. 167-176
-
Impact of Epicardial Adipose Tissue on Infarct Size and Left Ventricular Systolic Function in Patients with Anterior ST-Segment Elevation Myocardial Infarction
Diagnostics, Vol. 14, Núm. 4
-
Noncardiovascular morbidity and mortality across left ventricular ejection fraction categories following hospitalization for heart failure
Revista Espanola de Cardiologia, Vol. 77, Núm. 3, pp. 206-214
-
Short-Course High-Intensity Statin Treatment during Admission for Myocardial Infarction and LDL-Cholesterol Reduction—Impact on Tailored Lipid-Lowering Therapy at Discharge
Journal of Clinical Medicine, Vol. 13, Núm. 1
-
Urinary Cell Cycle Arrest Biomarkers and Diuretic Efficiency in Acute Heart Failure
CardioRenal Medicine, Vol. 14, Núm. 1, pp. 261-269
-
β-Blocker Withdrawal and Functional Capacity Improvement in Patients with Heart Failure with Preserved Ejection Fraction
JAMA Cardiology, Vol. 9, Núm. 4, pp. 392-396
2023
-
An update on utilising brain natriuretic peptide for risk stratification, monitoring and guiding therapy in heart failure
Expert Review of Molecular Diagnostics, Vol. 23, Núm. 6, pp. 521-533
-
Changes in the Treatment Strategy Following Intracoronary Pressure Wire in a Contemporaneous Real-Life Cohort of Patients With Intermediate Coronary Stenosis. Results From a Nationwide Registry
Cardiovascular Revascularization Medicine, Vol. 51, pp. 55-64
-
Chronotropic index and long-term outcomes in heart failure with preserved ejection fraction
Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 511-518
-
Clinical Predictors and Prognosis of Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) without ST-Segment Elevation in Older Adults
Journal of Clinical Medicine, Vol. 12, Núm. 3
-
Early glomerular filtration rate decline is associated with hemoglobin rise following dapagliflozin initiation in heart failure with reduced ejection fraction
Revista Espanola de Cardiologia, Vol. 76, Núm. 10, pp. 783-792
-
Long-term outcomes of extended DAPT in a real-life cohort of consecutive STEMI patients
Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 548-554
-
Performance of an artificial intelligence chatbot with web search capability in cardiology-related assistance: a simulation study
Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1065-1067
-
Risk of death associated with incident heart failure in patients with known or suspected chronic coronary syndrome
ESC Heart Failure, Vol. 10, Núm. 1, pp. 264-273
-
Role of plasma carbohydrate antigen 125 to identify nonfrail patients in HF
REC: CardioClinics, Vol. 58, Núm. 3, pp. 172-179